{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:21:13Z","timestamp":1787631673283,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Healthcare Committee, Region V\u00e4stra G\u00f6taland, SWEDEN. Grant number VGFOUREG-64832."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41409-019-0468-6","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T17:03:59Z","timestamp":1549299839000},"page":"1482-1488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cryotherapy as prophylaxis against oral mucositis after high-dose melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial"],"prefix":"10.1038","volume":"54","author":[{"given":"Jan-Erik","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bratel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Hardling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Heikki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf-Henrik","family":"Mellqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Hass\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"468_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/bmt.2015.6","volume":"50","author":"A Sureda","year":"2015","unstructured":"Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015;50:1037\u201356.","journal-title":"Bone Marrow Transplant"},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015;21:1863\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/bmt.2016.20","volume":"51","author":"JR Passweg","year":"2016","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51:786\u201392.","journal-title":"Bone Marrow Transplant"},{"key":"468_CR4","unstructured":"D\u2019Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT), CIBMTR Summary Slides, http:\/\/www.cibmtr.org . 2017."},{"key":"468_CR5","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19:2201\u20135.","journal-title":"J Clin Oncol"},{"key":"468_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/sj.bmt.1705384","volume":"37","author":"K Lilleby","year":"2006","unstructured":"Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006;37:1031\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1200\/JCO.1991.9.3.449","volume":"9","author":"DJ Mahood","year":"1991","unstructured":"Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 1991;9:449\u201352.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"468_CR8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2008.2001","volume":"6","author":"W Bensinger","year":"2008","unstructured":"Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw. 2008;6(Suppl 1):S1\u201321. quiz S2\u20134","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 6","key":"468_CR9","doi-asserted-by":"crossref","first-page":"vi78","DOI":"10.1093\/annonc\/mdr391","volume":"22","author":"DE Peterson","year":"2011","unstructured":"Peterson DE, Bensadoun RJ, Roila F, Group EGW. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(Suppl 6):vi78\u201384.","journal-title":"Ann Oncol"},{"key":"468_CR10","doi-asserted-by":"crossref","unstructured":"Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011:CD000978.","DOI":"10.1002\/14651858.CD000978.pub5"},{"key":"468_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120:1453\u201361.","journal-title":"Cancer"},{"key":"468_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109:820\u201331.","journal-title":"Cancer"},{"key":"468_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2125.2010.03638.x","volume":"69","author":"CE Nath","year":"2010","unstructured":"Nath CE, Shaw PJ, Trotman J, Zeng L, Duffull SB, Hegarty G, et al. Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. Br J Clin Pharmacol. 2010;69:484\u201397.","journal-title":"Br J Clin Pharmacol"},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/cpt.644","volume":"102","author":"YK Cho","year":"2017","unstructured":"Cho YK, Sborov DW, Lamprecht M, Li J, Wang J, Hade EM, et al. Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial. Clin Pharmacol Ther. 2017;102:511\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"468_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bmt.1705494","volume":"38","author":"T Mori","year":"2006","unstructured":"Mori T, Aisa Y, Yamazaki R, Mihara A, Ikeda Y, Okamoto S. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis. Bone Marrow Transplant. 2006;38:637\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"468_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpainsymman.2011.08.012","volume":"44","author":"P Salvador","year":"2012","unstructured":"Salvador P, Azusano C, Wang L, Howell D. A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. J Pain Symptom Manag. 2012;44:64\u201373.","journal-title":"J Pain Symptom Manag"},{"key":"468_CR17","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348.","journal-title":"Lancet Oncol"},{"key":"468_CR18","volume-title":"WHO handbook for reporting results of cancer treatment.","author":"World Health Organization.","year":"1979","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatment.. Geneva: World Health Organization; 1979."},{"key":"468_CR19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0","volume":"85","author":"ST Sonis","year":"1999","unstructured":"Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr., Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85:2103\u201313.","journal-title":"Cancer"},{"key":"468_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.bmt.1705471","volume":"38","author":"ML Grazziutti","year":"2006","unstructured":"Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N, et al. Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant. 2006;38:501\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"468_CR21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","volume":"44","author":"S Janmahasatian","year":"2005","unstructured":"Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051\u201365.","journal-title":"Clin Pharmacokinet"},{"key":"468_CR22","doi-asserted-by":"crossref","unstructured":"Rodriguez M, Devlin S, Giralt S, Landau H. Cryotherapy reduces mucositis in multiple myeloma patients receiving high-dose melphalan conditioning prior to autologous stem cell transplantation. Blood. 2012;120:4265.","DOI":"10.1182\/blood.V120.21.4265.4265"},{"key":"468_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/ejh.12386","volume":"93","author":"M Batlle","year":"2014","unstructured":"Batlle M, Morgades M, Vives S, Ferra C, Oriol A, Sancho JM, et al. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma. Eur J Haematol. 2014;93:487\u201391.","journal-title":"Eur J Haematol"},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/bmt.2016.207","volume":"52","author":"F Marchesi","year":"2017","unstructured":"Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D, et al. Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. Bone Marrow Transplant. 2017;52:154\u20136.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0468-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0468-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:07Z","timestamp":1684617247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0468-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0468-6","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"27 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}